Answers are grounded in this paper and cite their sources.
Insulin resistance (IR) is becoming more common in pediatric populations, mainly due to the rise in childhood obesity prevalence. It is often associated with a combination of sedentary lifestyle, genetic predisposition, and poor dietary choices. The main pathophysiological factors include excessive adiposity, chronic low-grade inflammation, and altered adipokine secretion, which impair insulin signaling. As adipose tissue expands, particularly if in the visceral compartment, increased release of pro-inflammatory mediators can further disrupt insulin signaling and promote metabolic dysfunction. These changes may begin during childhood and progress throughout adolescence, particularly when excess weight and unhealthy lifestyle patterns persist. Moreover, puberty itself is associated with a temporary physiological reduction in insulin sensitivity, which may further increase metabolic vulnerability during this developmental period. The consequences of insulin resistance during adolescence extend beyond impaired insulin action and may include hypertension, dyslipidemia, an increased risk of type 2 diabetes, and cardiovascular disease later in life. Early identification of children at increased metabolic risk and timely lifestyle interventions may help prevent or delay long-term metabolic complications. Understanding the systemic and complex nature of IR in adolescents is vital for guiding therapeutic measures and preventing the development of severe complications. The aim of this narrative review was to summarize the current state of knowledge on obesity-related insulin resistance in children and adolescents, focusing on its pathogenesis, metabolic implications, associated risks, and current therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Majewska et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: